Our attitudes and behaviours are shaped by what others in society do. So there’s a real danger that vaccine hesitancy, when reported widely in the media, could catch on to more people.
One of this and one of that might be a good strategy to coronavirus vaccination.
SOPA Images/LightRocket via Getty Images
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it’s better for individuals to mix what’s available.
Experts are continually monitoring how well COVID vaccines are working, their side effects, and the amount of disease in the community. These factors can change, and advice will adapt accordingly.
Both the AstraZeneca and Pfizer vaccines still work relatively well against it — though only after the second dose.
Pharmacist Barbara Violo arranges all the empty vials of the AstraZeneca COVID-19 vaccine that she has provided to customers at an independent pharmacy in Toronto.
THE CANADIAN PRESS/Nathan Denette
Hundreds of thousands of Canadians got a shot of AstraZeneca’s COVID-19 vaccine for their first dose. They now have a choice for their second dose: AstraZeneca again, or Pfizer or Moderna mRNA vaccine?
Kylie Quinn, RMIT University and Jennifer Juno, The Peter Doherty Institute for Infection and Immunity
The infection of a Victorian aged-worker who had received their first COVID vaccine dose isn’t completely surprising. We need two doses for optimal protection.
A healthcare worker holds up a vial of the AstraZeneca vaccine at a COVID-19 vaccination clinic in Montréal, on March 18.
THE CANADIAN PRESS/Paul Chiasson
Answers to key questions about rare blood clots linked to AstraZeneca’s COVID-19 vaccine, including risks, symptoms and whether people who have had one AstraZeneca shot should have a second.
We want to get everybody vaccinated. Opening up to younger age groups could be one way to speed things up — but it will come with logistical challenges too.
Fiona Russell, The University of Melbourne; John Hart, Murdoch Children's Research Institute, and Katherine Gibney, The Peter Doherty Institute for Infection and Immunity
The COVID-19 variant responsible for Victoria’s latest outbreak is one of three Indian variant sub-types, which spreads more easily than the original strain. Here’s what we know so far.
The increased infectiousness of B16172 could magnify the impact of vaccines being less effective against it.
This giant effigy of the SARS-CoV-2 coronavirus is intended to be burned as part of the Holika Dahan, during which the demon Holika is led to the stake on the eve of the Holi celebrations, a popular Hindu festival.
Sujit Jaiswal/AFP